Literature DB >> 34167947

Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response.

Fredrik N Albach1, Gerd R Burmester1, Robert Biesen2.   

Abstract

Entities:  

Keywords:  COVID-19; Methotrexate; Rheumatoid Arthritis; Vaccination

Year:  2021        PMID： 34167947     DOI： 10.1136/annrheumdis-2021-220834

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  8 in total

1.  Attenuated response to fourth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series.

Authors:  Mayan Teles; Caoilfhionn M Connolly; Sarah Frey; Teresa Po-Yu Chiang; Jennifer L Alejo; Brian J Boyarsky; Ami A Shah; Jemima Albayda; Lisa Christopher-Stine; William A Werbel; Dorry L Segev; Julie J Paik
Journal:  Ann Rheum Dis       Date:  2022-01-17       Impact factor: 19.103

Review 2.  Axillary Lymph Node Swelling After COVID-19 Booster Vaccination: Japanese Case Report and Literature Review.

Authors:  Nobuyasu Yoshimoto; Akemi Yanagi; Satoru Takayama; Masaki Sakamoto; Keisuke Tomoda; Ken Ishikawa; Akifumi Kawate; Shoryu Takayama; Masakatsu Yamashita; Shinya Yamamoto; Kioto Yokoyama; Hiroto Suzuki; Hisanori Kani
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

3.  Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination.

Authors:  Davide Firinu; Andrea Perra; Marcello Campagna; Roberto Littera; Giuseppe Fenu; Federico Meloni; Selene Cipri; Francesca Sedda; Maria Conti; Michela Miglianti; Giulia Costanzo; Marta Secci; Gianmario Usai; Mauro Giovanni Carta; Riccardo Cappai; Germano Orrù; Stefano Del Giacco; Ferdinando Coghe; Luchino Chessa
Journal:  Clin Exp Med       Date:  2021-11-05       Impact factor: 5.057

4.  SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry.

Authors:  Jean Liew; Milena Gianfrancesco; Carly Harrison; Zara Izadi; Stephanie Rush; Saskia Lawson-Tovey; Lindsay Jacobsohn; Clairissa Ja; Kimme L Hyrich; Laure Gossec; Anja Strangfeld; Loreto Carmona; Martin Schäfer; Elsa Frãzao-Mateus; Inita Bulina; Frances Stafford; Abdurrahman Tufan; Christine Graver; Gözde Kübra Yardımcı; Julija Zepa; Samar Al Emadi; Claire Cook; Fatemah Abutiban; Dfiza Dey; Genevieve Katigbak; Lauren Kaufman; Emily Kowalski; Marco Ulises Martínez-Martínez; Naomi J Patel; Greta Reyes-Cordero; Evelyn Salido; Ellison Smith; David Snow; Jeffrey Sparks; Leanna Wise; Suleman Bhana; Monique Gore-Massy; Rebecca Grainger; Jonathan Hausmann; Emily Sirotich; Paul Sufka; Zachary Wallace; Pedro M Machado; Philip C Robinson; Jinoos Yazdany
Journal:  RMD Open       Date:  2022-04

5.  Role of booster with BNT162b2 mRNA in SARS-CoV-2 vaccination in patients with rheumatoid arthritis.

Authors:  Maurizio Benucci; Arianna Damiani; Francesca Li Gobbi; Barbara Lari; Valentina Grossi; Maria Infantino; Mariangela Manfredi
Journal:  Immunol Res       Date:  2022-05-11       Impact factor: 4.505

6.  BNT162b2 mRNA COVID-19 vaccine and booster in patients with autoimmune rheumatic diseases: a national cohort study.

Authors:  Amir Bieber; Iftach Sagy; Lena Novack; Shay Brikman; Ran Abuhasira; Snait Ayalon; Irina Novofastovski; Mahmoud Abu-Shakra; Reuven Mader
Journal:  Ann Rheum Dis       Date:  2022-04-13       Impact factor: 27.973

7.  Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination.

Authors:  Elisa Habermann; Lutz Gieselmann; Pinkus Tober-Lau; Jens Klotsche; Fredrik Nils Albach; Alexander Ten Hagen; Jan Zernicke; Elvin Ahmadov; Amanthi Nadira Arumahandi de Silva; Leonie Maria Frommert; Florian Kurth; Leif Erik Sander; Gerd R Burmester; Florian Klein; Robert Biesen
Journal:  RMD Open       Date:  2022-10

8.  Reply.

Authors:  David Simon; Filippo Fagni; Koray Tascilar; Georg Schett
Journal:  Arthritis Rheumatol       Date:  2022-03-20       Impact factor: 15.483
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.